jixi66
Lv21
150 积分
2023-11-24 加入
-
2025年最新痛风及高尿酸血症基层诊疗指南
1个月前
已关闭
-
Hyperuricemia, the kidneys, and the spectrum of associated diseases: a narrative review
2个月前
已完结
-
2015年美国风湿病学会/欧洲抗风湿病联盟痛风分类标准评述
5个月前
已完结
-
Sun J, Wang Y, Zhang X, et al. POS0255 A RANDOMIZED, MULTICENTER, DOUBLE-BLIND, PHASE 3 STUDY COMPARING EFFICACY OF DOTINURAD AND FEBUXOSTAT FO
8个月前
已关闭
-
Pharmacokinetics and pharmacodynamics of febuxostat, a new non-purine selective inhibitor of xanthine oxidase in subjects with renal impairment
9个月前
已完结
-
POS0255 A RANDOMIZED, MULTICENTER, DOUBLE-BLIND, PHASE 3 STUDY COMPARING EFFICACY OF DOTINURAD AND FEBUXOSTAT FOR THE TREATMENT OF GOUT IN CHINESE SUBJECTS
9个月前
已关闭
-
138亿年的旅程
9个月前
已关闭
-
Drug-Induced Hypouricemia
10个月前
已关闭
-
Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial
11个月前
已完结
-
FAST: new look at the febuxostat safety profile
11个月前
已完结